(Q81124588)

English

Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma

scientific article published on 01 October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

ovarian carcinoma

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Tiina-Liisa Erkinheimo

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Anna Sivula

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Mira Heinonen

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Caj Haglund

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Ralf Butzow

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Ari Ristimäki

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 October 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

99

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

14-19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Heterogeneity of ovarian cancer: relationships among histological group, stage of disease, tumor markers, patient characteristics, and survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Elevated cyclooxygenase-2 expression is associated with altered expression of p53 and SMAD4, amplification of HER-2/neu, and poor outcome in serous ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

The effect of cyclooxygenase‐2 expression on tumor vascularity in advanced stage ovarian serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

The proximal region of the 3'-untranslated region of cyclooxygenase-2 is recognized by a multimeric protein complex containing HuR, TIA-1, TIAR, and the heterogeneous nuclear ribonucleoprotein U

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

The RNA-binding protein HuR regulates the expression of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Prognostic impact of chromosome aberrations in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Inhibition of cyclooxygenase-2 gene expression by p53.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Cyclooxygenase-2 expression during carcinogenesis in the human stomach.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Prostaglandin E2 induces inhibin alpha- and beta A-subunit mRNA and secretion of dimeric inhibin A in cultured human granulosa-luteal cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.047

7 January 2021

Identifiers

10.1016/J.YGYNO.2005.04.047

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16126263%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81124588&oldid=1506778221"